6-K ·Filed Apr 30, 2026
Notable filing: 6-K
Actionable Insight • Neutral
No trading action warranted. Monitor the AGM date for shareholder approval, but this is a routine governance event without material price implications.
Final — all horizons settled through T+60d ⚠ clustered
PRQR ▲ +10.19% at T+60d
NEUTRAL call +10.19% · α vs SPY +7.08% · entry $1.57 → $1.73
T+1d
-1.27%
call -1.27% · α -1.49%
$1.55
settled 6mo ago
T+5d
+9.55%
call +9.55% · α +7.83%
$1.72
settled 6mo ago
T+20d
0.00%
call 0.00% · α -4.97%
$1.57
settled 5mo ago
T+60d
+10.19%
call +10.19% · α +7.08%
$1.73
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
ProQR announced the nomination of Dr. Lykke Hinsch Gylvin, CMO of Boehringer Ingelheim, to its Board of Directors, subject to shareholder approval at the upcoming AGM. This is a routine board addition with no financial or operational impact.
Key Facts
- Nomination of Dr. Lykke Hinsch Gylvin to the Board of Directors.
- Dr. Gylvin is Chief Medical Officer and Head of Global Medicine at Boehringer Ingelheim.
- Nomination requires shareholder approval at the Annual General Meeting.
- No financial terms, material agreements, or changes to operations disclosed.
Financial Impact
No financial impact; routine board nomination.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (15 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-052201 |
| Document: tm2613009d1_6k.htm | 0001104659-26-052201 |
| Document: 0001104659-26-052201-index-headers.html | 0001104659-26-052201 |
| Document: 0001104659-26-052201-index.html | 0001104659-26-052201 |
| Document: 0001104659-26-052201.txt | 0001104659-26-052201 |
14 reports for PRQR
40% Hit rate @ T+5 Went positive at some point 3 of 5 best @ T+20▲ +11.88%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | 6-K | $1.70 $1.66 | ▼ −2.35% | ▼ −1.68% | $1.32 (−22.40%) |
Sep 9, 2026 6w ago | 6-K | $1.99 $1.86 | ▼ −6.53% | ▼ −5.44% | $1.32 (−33.71%) |
Jul 16, 2026 14w ago | EFFECT | $1.67 $1.79 | ▼ −7.19% | ▼ −8.86% | $1.32 (+21.01%) |
Jun 25, 2026 17w ago | 6-K | $1.53 $1.81 | ▼ −18.30% | ▼ −16.13% | $1.32 (+13.78%) |
Jun 25, 2026 17w ago | 424B5 | $1.53 $1.81 | ▲ +18.30% | ▲ +16.13% | $1.32 (−13.78%) |
Jun 2, 2026 20w ago | 6-K | $1.47 $1.41 | ▼ −4.08% | ▼ −0.26% | $1.32 (−10.26%) |
May 12, 2026 24w ago | 6-K | $1.60 $1.51 | ▲ +5.63% | ▲ +5.70% | $1.32 (+17.55%) |
Apr 30, 2026 25w ago | 6-K | $1.57 $1.72 | ▲ +9.55% | ▲ +7.83% | $1.32 (−15.97%) |
Apr 30, 2026 25w ago | Press Release | $1.57 $1.72 | ▲ +9.55% | ▲ +7.83% | $1.32 (−15.97%) |
Apr 8, 2026 28w ago | 6-K | $1.98 $1.95 | ▼ −1.52% | ▼ −4.70% | $1.32 (−33.37%) |
Showing 10 of 14
US Market Status
Market Open — Closes in 2h 33m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers